Recent literature presents a fragmented view of proteostasis collapse in aging: we see translation defects in some models, cytoskeletal breakdown in others, and volume-dependent toxicity in bacteria. I propose these are not parallel phenomena, but sequential steps in a unified mechanistic cascade.

The Hypothesis

I hypothesize that age-associated actin cytoskeleton destabilization is the primary mechanical upstream driver of the ribosome stalling observed in aged neurons.

Specifically, the loss of actin structural integrity disrupts the spatial scaffolding of polysomes, forcing localized molecular crowding of mRNA that directly induces ribosome collisions. Because a functioning actin network is simultaneously required to transport misfolded Defective Ribosomal Products (DRiPs) into a sequestered aggresome, these nascent aggregates diffuse throughout the cytoplasm. This drives a rapid increase in the fraction of intracellular volume occupied by aggregates—which ultimately triggers cellular collapse.

Mechanistic Synthesis

1. Actin De-scaffolding Induces Ribosome Collisions We know that in aging fish brains, proteostasis fails when ribosomes collide and stall on mRNA. However, the cause of these collisions remains elusive. In parallel, it has been shown that aging increases USP-4 levels, stabilizing EPS-8 and hyperactivating RAC signaling, which drives aggregation through actin cytoskeleton destabilization. I argue that these findings are mechanistically linked. Polysomes are physically tethered to the actin cytoskeleton to maintain efficient translational spacing. When the USP-4/EPS-8/RAC axis destabilizes actin, polysomes lose their spatial anchor, leading to physical clustering, translation elongation traffic jams, and inevitable ribosome collisions.

2. The "Spatial Fraction" Toxicity Model in Post-Mitotic Cells Bacterial models recently demonstrated that the decisive factor driving fitness decline is not the mere presence of aggregates but the fraction of intracellular space they occupy. While bacteria can partially buffer this by increasing cell size, post-mitotic mammalian neurons face a strict volumetric constraint. When actin collapses, the cell loses its ability to retrogradely transport stalled DRiPs to the perinuclear aggresome via dynein. Instead of forming one dense, easily managed inclusion, the aggregates remain dispersed, exponentially increasing the fraction of intracellular space they occupy and mechanically interfering with remaining organelle function.

Testable Predictions

To falsify or validate the CTSC Hypothesis, I propose the following experiments:

• Prediction 1 (Ribosome Collision Rescue): If actin collapse drives translation failure, then pharmacological stabilization of actin (e.g., using jasplakinolide at low doses) or knocking down usp-4 in aged human ALS neurons should not merely reduce overall aggregates, but specifically rescue translation elongation rates and prevent ribosome collisions (measurable via Ribo-Seq).
• Prediction 2 (Volumetric Toxicity in Mammals): The toxicity of the neuronal aggregome is a function of its spatial distribution, not just its mass. Using spatial proteomics and 3D electron tomography, we should observe that cells with dispersed, non-compartmentalized micro-aggregates (occupying a higher % of cytoplasmic volume) undergo apoptosis earlier than cells containing an equivalent mass of aggregated protein packed into a single, dense aggresome.
• Prediction 3 (Synergistic Intervention): Interventions that purely enhance clearance—such as activating lysosomal function to clear aggregates—will show diminishing returns in aged cells if the translation-actin scaffold is not repaired. Dual therapy combining an actin stabilizer (or RAC inhibitor) with an autophagy activator (like rapamycin) will show a supra-additive extension of neuronal viability.

By framing proteostasis collapse as a biomechanical and spatial failure rather than purely a biochemical one, we can better target the physical roots of the aging aggregome.